glutathione reductase diabetes Frontiers Aldose Reductase (AR, ALR2) |

Echinocandins inhibit the synthesis of the fungal cell wall component -(1,3)-D-glucan by targeting the -(1,3)-glucan synthase (216)

The clinical symptoms that result from this process include progressive muscle weakness, atrophy, speech and swallowing difficulties, as well as respiratory complications (Mejzini et al., 2019

J.PogueA.HillJ

Several numerical values were updated as well

Disclosures: Deeksha Kartik: Nothing to Disclose, Lara Murray: Nothing to Disclose, Jacqueline Brosnan-Cashman: PathAI: Employee, PathAI: Stock privately held company, Neel Patel: PathAI: Employee, Ylaine Gerardin: PathAI: Employee, Robert Egger: Nothing to Disclose, Adam Stanford-Moore: Nothing to Disclose 826 SIMPLE NONINVASIVE TESTS HAVE POOR DIAGNOSTIC ACCURACY FOR MASLD F2-3 IN A REAL WORLD CANADIAN COHORT Nashla Hamdan 1 Chinmay Bera 2 Heather Kosick 1 Keyur Patel 1 , 1 University of Toronto, 2 Toronto General Hospital Background: Several Non-invasive test (NIT) that have been proposed to identify patients with advanced fibrosis (F3-4) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)